Abstract
Background: The therapeutic strategies to manage neurodegenerative diseases remain limited and it is necessary to discover new agents for their prevention and control. Oxidative stress and inflammation play a main role in the pathogenesis of neurodegenerative diseases. The aim of this study is to review the effects of green tea catechins against the Neurodegenerative Diseases.
Methods: In this study, we extensively reviewed all articles on the terms of Green tea, catechins, CNS disorders, and different diseases in PubMed, Science Direct, Scopus, and Google Scholar databases between the years 1990 and 2017.
Results: The present study found that catechins, the major flavonoids in green tea, are powerful antioxidants and radical scavengers which possess the potential roles in the management of neurodegenerative diseases. Catechins modulate the cellular and molecular mechanisms through the inflammation-related NF-κB and the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways.
Conclusion: The findings of the present review shows catechins could be effective against neurodegenerative diseases due to their antioxidation and anti-inflammation effects and the involved biochemical pathways including Nrf2 and NF-kB signaling pathways.
Keywords: Neurodegenerative diseases, green tea, catechins, antioxidant, anti-inflammation, therapeutic strategies.
Graphical Abstract
[1]
Goodarzi F, Mehrpour O, Eizadi-Mood N. A study to evaluate factors associated with seizure in tramadol poisoning in Iran. Indian J Forensic Med Toxicol 2011; 5(2): 66-9.
[2]
Samarghandian S, Azimi-Nezhad M, Borji A, Farkhondeh T. Effect of crocin on aged rat kidney through inhibition of oxidative stress and proinflammatory state. Phytother Res 2016; 30(8): 1345-53.
[3]
Hajzadeh MAR, Rajaei Z, Shafiee S, Alavinejhad A, Samarghandian S, Ahmadi M. Effect of barberry fruit (Berberis Vulgaris) on serum glucose and lipids in streptozotocin-diabetic rats. Pharmacologyonline 2011; 1: 809-17.
[4]
Cummings JL, Zhong K. Treatments for behavioural disorders in neurodegenerative diseases: Drug development strategies. Nat Rev Drug Discov 2006; 5(1): 64-74.
[5]
Grube S, Ewald C, Kögler C, Lawson McLean A, Kalff R, Walter J. Achievable central nervous system concentrations of the green tea catechin EGCG induce stress in glioblastoma cells in vitro. Nutr Cancer 2018; 1-14.
[6]
Farzaei MH, Bahramsoltani R, Abbasabadi Z, Braidy N, Nabavi SM. Role of green tea catechins in prevention of age-related cognitive decline: Pharmacological targets and clinical perspective. J Cell Physiol 2018.
[http://dx.doi.org/10.1002/jcp.27289]
[http://dx.doi.org/10.1002/jcp.27289]
[7]
Cabrera C, Giménez R, López MC. Determination of tea components with antioxidant activity. Agric Food Chem 2003; 51: 4427-35.
[8]
Jówko E. Green tea catechins and sport performance.In: Antioxidants in sport nutrition. Chapter 8 UK: Taylor and Francis Group 2015; 17: 123.
[9]
Santamaría-del Ángel D, Labra-Ruíz NA, García-Cruz ME, Calderón-Guzmán D, Valenzuela-Peraza A, Juárez-Olguín H. Comparative effects of catechin, epicatechin and N-Ω-nitroarginine on quinolinic acid-induced oxidative stress in rat striatum slices. Biomed Pharmacother 2016; 78: 210-5.
[10]
Zhang W, Feng X, Alula Y, Yao S. Bionic multi-tentacled ionic liquid-modified silica gel for adsorption and separation of polyphenols from green tea (Camellia sinensis) leaves. Food Chem 2017; 230: 637-48.
[11]
Guo Y, Guo Y, Xie Y, Cheng Y, Qian H, Yao W. Regeneration of tert-butylhydroquinone by tea polyphenols. Food Res Int 2017; 95: 1-8.
[12]
Castellano-González G, Pichaud N, Ballard JW, Bessede A, Marcal H, Guillemin GJ. Epigallocatechin-3-gallate induces oxidative phosphorylation by activating cytochrome c oxidase in human cultured neurons and astrocytes. Oncotarget 2016; 7: 7426.
[13]
Wang J, Liu W, Chen Z, Chen H. Physicochemical characterization of the oolong tea polysaccharides with high molecular weight and their synergistic effects in combination with polyphenols on hepatocellular carcinoma. Biomed Pharmacother 2017; 90: 160-70.
[14]
He X, Liu B. Oolong tea extract as a substitute for uranyl acetate in staining of ultrathin sections based on examples of animal tissues for transmission electron microscopy. J Microsc 2017; 267(1): 27-33.
[15]
Renno WM, Khan KM, Benov L. Is there a role for neurotrophic factors and their receptors in augmenting the neuroprotective effect of (−)-epigallocatechin-3-gallate treatment of sciatic nerve crush injury? Neuropharmacology 2016; 102: 1-20.
[17]
Samarghandian S, Azimi-Nezhad M, Farkhondeh T. Catechin treatment ameliorates diabetes and its complications in streptozotocin-induced diabetic rats. Dose Response 2017; 15(1): 1559325817691158.
[18]
Sironi E, Colombo L, Lompo A, et al. Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1–42, PrP106-126, and Ataxin‐3 Oligomers. Chemistry 2014; 20(42): 13793-800.
[19]
Nichols M, Zhang J, Polster BM, et al. Synergistic neuroprotection by epicatechin and quercetin: activation of convergent mitochondrial signaling pathways. Neuroscience 2015; 308: 75-94.
[20]
Cong L, Cao C, Cheng Y, Qin XY. Green tea polyphenols attenuated glutamate excitotoxicity via antioxidative and antiapoptotic pathway in the primary cultured cortical neurons. Oxid Med Cell Longev 2016; 2016: 2050435.
[21]
Altermann CD, Souza MA, Schimidt HL, et al. Short-term green tea supplementation prevents recognition memory deficits and ameliorates hippocampal oxidative stress induced by different stroke models in rats. Brain Res Bull 2017; 131: 78-84.
[22]
He Q, Bao L, Zimering J, et al. The protective role of (−)-epigallocatechin-3-gallate in thrombin-induced neuronal cell apoptosis and JNK-MAPK activation. Neuroreport 2015; 26: 416-23.
[23]
Bhattacharya TK, Pence BD, Ossyra JM, et al. Exercise but not (–)-epigallocatechin-3-gallate or β-alanine enhances physical fitness, brain plasticity, and behavioral performance in mice. Physiol Behav 2015; 145: 29-37.
[24]
Assuncao M, Andrade JP. Protective action of green tea catechins in neuronal mitochondria during aging. Front Biosci(Landmark Ed) 2014; 20: 247-62.
[25]
Zhao X, Li R, Jin H, et al. Epigallocatechin-3-gallate confers protection against corticosterone-induced neuron injuries via restoring extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3 kinase/protein kinase B signaling pathways. PLoS One 2018; 13(1): e0192083.
[26]
Mehrpour O, Karrari P, Abdollahi M. Chronic lead poisoning inIran; a silent disease. Daru 2012; 20(1): 8.
[http://dx.doi.org/10.1186/2008-2231-20-8]
[http://dx.doi.org/10.1186/2008-2231-20-8]
[27]
Yu NH, Pei H, Huang YP, Li YF. (-)-Epigallocatechin-3-Gallate Inhibits Arsenic-Induced Inflammation and Apoptosis through Suppression of Oxidative Stress in Mice. Cell Physiol Biochem 2017; 41(5): 1788-800.
[28]
Abdul Qadir M, Shahzadi SK, Bashir A, Munir A, Shahzad S. Evaluation of Phenolic Compounds and Antioxidant and Antimicrobial Activities of Some Common Herbs. Int J Anal Chem 2017; 2017: 3475738.
[29]
Raposo D, Morgado C, Pereira-Terra P, Tavares I. Nociceptive spinal cord neurons of laminae I–III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG). Brain Res Bull 2015; 110: 68-75.
[30]
Shen C, Cheng W, Yu P, et al. Resveratrol pretreatment attenuates injury and promotes proliferation of neural stem cells following oxygen-glucose deprivation/reoxygenation by upregulating the expression of Nrf2, HO-1 and NQO1 in vitro. Mol Med Rep 2016; 14: 3646-54.
[31]
Leonardo CC, Agrawal M, Singh N, Moore JR, Biswal S, Doré S. Oral administration of the flavanol (−)‐epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway. Eur J Neurosci 2013; 38: 3659-868.
[32]
Qu Z, Meng F, Zhou H, et al. NitroDIGE analysis reveals inhibition of protein S-nitrosylation by epigallocatechin gallates in lipopolysaccharide-stimulated microglial cells. J Neuroinflammation 2014; 11: 17.
[33]
Han J, Wang M, Jing X, Shi H, Ren M, Lou H. (−)-Epigallocatechin gallate protects against cerebral ischemia-induced oxidative stress via Nrf2/ARE signaling. Neurochem Res 2014; 39: 1292-9.
[34]
Wong KL, Wu YR, Cheng KS, et al. Palmitic acid-induced lipotoxicity and protection by (+)-catechin in rat cortical astrocytes. Pharmacol Rep 2014; 66: 1106-13.
[35]
Salameh A, Einenkel A, Kühne L, et al. Hippocampal neuroprotection by minocycline and Epigallo‐Catechin‐3‐Gallate against cardiopulmonary bypass‐associated injury. Brain Pathol 2015; 25: 733-42.
[36]
Bhatia G, Dhuna V, Dhuna K, Kaur M, Singh J. Bacopa monnieri extracts prevent hydrogen peroxide-induced oxidative damage in a cellular model of neuroblastoma IMR32 cells. Chin J Nat Med 2017; 15(11): 834-46.
[37]
He M, Liu MY, Wang S, et al. Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs. Zhong Yao Cai 2012; 35: 1641-4.
[38]
Halevas E, Nday CM, Salifoglou A. Hybrid catechin silica nanoparticle influence on Cu (II) toxicity and morphological lesions in primary neuronal cells. J Inorg Biochem 2016; 163: 240-9.
[39]
Ortiz-López L, Márquez-Valadez B, Gómez-Sánchez A, et al. Green tea compound epigallo-catechin-3-gallate (EGCG) increases neuronal survival in adult hippocampal neurogenesis in vivo and in vitro. Neuroscience 2016; 322: 208-320.
[40]
Kohl Z, Schlachetzki JC, Feldewerth J, et al. Distinct pattern of microgliosis in the olfactory bulb of neurodegenerative proteinopathies. Neural Plast 2017; 2017: 3851262.
[41]
McKenzie JA, Spielman LJ, Pointer CB, et al. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer’s and Parkinsons Diseases Curr Aging Sci 2017; 10(3): 158-76.
[42]
Chen M, Wang T, Yue F, et al. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys. Neuroscience 2015; 286: 383-92.
[43]
Ge R, Zhu Y, Diao Y, Tao L, Yuan W, Xiong XC. Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats. Brain Res 2013; 1527: 40-6.
[44]
Zhang F, Li N, Jiang L, Chen L, Huang M. Neuroprotective effects of (−)-epigallocatechin-3-gallate against focal cerebral ischemia/reperfusion injury in rats through attenuation of inflammation. Neurochem Res 2015; 40: 1691-8.
[45]
Wang XH, You YP. Epigallocatechin gallate extends therapeutic window of recombinant tissue plasminogen activator treatment for brain ischemic stroke: A randomized double-blind and placebo-controlled trial. Clin Neuropharmacol 2017; 40: 24-8.
[46]
Wightman EL1. Haskell CF, Forster JS, Veasey RC, Kennedy DO. Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double‐blind, placebo‐controlled, crossover investigation. Hum Psychopharmacol 2012; 27: 177-86.
[48]
Shahidi S, Zargooshnia S, Asl SS, Komaki A, Sarihi A. Influence of N-acetyl cysteine on beta-amyloid-induced Alzheimer’s disease in a rat model: A behavioral and electrophysiological study. Brain Res Bull 2017; 131: 142-9.
[49]
Mehrpour O. Addiction and seizure ability of tramadol in high-risk patients. Indian J Anaesth 2013; 57(1): 86-7.
[50]
Alinejad S, Aaseth J, Abdollahi M, Hassanian-Moghaddam H, Mehrpour O. Clinical Aspects of Opium Adulterated with Lead in Iran: A Review. Basic Clin Pharmacol Toxicol 2018; 122(1): 56-64.
[51]
Samarghandian S, Azimi-Nezhad M, Borji A, et al. Inhibitory and Cytotoxic Activities of Chrysin on Human Breast Adenocarcinoma Cells by Induction of Apoptosis. Pharmacogn Mag 2016; 12(4): S436-40.
[52]
Samarghandian S, Azimi-Nezhad M, Samini F, Farkhondeh T. Chrysin treatment improves diabetes and its complications in liver, brain, and pancreas in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 2016; 94(4): 388-93.
[53]
Zhang X, Wu M, Lu F, Luo N, He ZP, Yang H. Involvement of α7 nAChR signaling cascade in epigallocatechin gallate suppression of β-amyloid-induced apoptotic cortical neuronal insults. Mol Neurobiol 2014; 49: 66-77.
[54]
Walker JM, Klakotskaia D, Ajit D, et al. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer’s disease mouse model. J Alzheimers Dis 2015; 44: 561-72.
[55]
Jia N, Han K, Kong JJ, et al. (−)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Mol Cell Biochem 2013; 380: 211-8.
[56]
George RC, Lew J, Graves DJ. Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer’s disease pathogenesis. J Alzheimers Dis 2013; 36: 21-40.
[57]
Jelenković A1. Jovanović MD, Stevanović I, Petronijević N, Bokonjić D, Zivković J, Igić R. Influence of the green tea leaf extract on neurotoxicity of aluminium chloride in rats. Phytother Res 2014; 281: 82-7.
[58]
Cavaliere F, Cerf L, Dehay B, et al. In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiol Dis 2017; 103: 101-12.
[59]
Ryu DW, Lee SH, Oh YS, et al. Clinical Characteristics of Parkinson’s Disease Developed from Essential Tremor. J Parkinsons Dis 2017; 7(2): 369-76.
[60]
Costa SL, Silva VD, dos Santos Souza C, et al. Impact of plant-derived flavonoids on neurodegenerative diseases. Neurotox Res 2016; 30(1): 41-52.
[61]
Csencsits-Smith K, Suescun J, Li K, Luo S, Bick DL, Schiess M. Serum lymphocyte-associated cytokine concentrations change more rapidly over time in multiple system atrophy compared to Parkinson disease. Neuroimmunomodulation 2016; 23(5-6): 301-8.
[62]
Xu YD, Cui C, Sun MF, et al. Neuroprotective effects of Loganin on MPTP-induced Parkinson’s disease mice: Neurochemistry, glial reaction and autophagy studies. J Cell Biochem 2017; 118(10): 3495-510.
[63]
Karuppagounder SS, Xiong Y, Lee Y, et al. LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity. J Chem Neuroanat 2016; 76(Pt B): 90-7
[64]
Mercer LD, Kelly BL, Horne MK, Beart PM. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol 2005; 69: 339-45.
[65]
Teixeira MD, Souza CM, Menezes AP, et al. Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats. Pharmacol Biochem Behav 2013; 110: 1-7.
[66]
AL-Amri JS. Hagras MM, Mujallid MI. Effect of epigallocatechin-3-gallate on inflammatory mediators release in LPS-induced Parkinson’s disease in rats. Indian J Exp Biol 2013; 51: 357-62.
[67]
Siddique YH, Jyoti S, Naz F. Effect of epicatechin gallate dietary supplementation on transgenic Drosophila model of Parkinson’s disease. J Diet Suppl 2014; 11: 121-30.
[68]
Zamani M, Rohampour K, Zeraati M, Hosseinmardi N, Kazemian MM. Pre-training Catechin gavage prevents memory impairment induced by intracerebroventricular streptozotocin in rats. Neurosciences (Riyadh) 2015; 20: 225.
[69]
Knezevic B, Lukowiak K. The flavonol epicatechin reverses the suppressive effects of a stressor on long-term memory formation. J Exp Biol 2014; 217: 4004-9.
[70]
Tseng HC, Wang MH, Soung HS, Chang Y, Chang KC. (−) Epigallocatechin-3-gallate prevents the reserpine-induced impairment of short-term social memory in rats. Behav Pharmacol 2015; 26: 741-7.
[71]
Lee B, Sur B, Kwon S, et al. Chronic administration of catechin decreases depression and anxiety-like behaviors in a rat model using chronic corticosterone injections. Biomol Ther (Seoul) 2013; 21(4): 313-22.
[72]
Stringer TP, Guerrieri D, Vivar C, Van Praag H. Plant-derived flavanol (−) epicatechin mitigates anxiety in association with elevated hippocampal monoamine and BDNF levels, but does not influence pattern separation in mice. Transl Psychiatry 2015; 5: e493.
[73]
De la Torre R, De Sola S, Pons M, et al. Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res 2014; 58: 278-88.
[74]
Stringer M, Abeysekera I, Dria KJ, Roper RJ, Goodlett CR. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. Pharmacol Biochem Behav 2015; 138: 70-9.
[75]
de la Torre R, de Sola S, Hernandez G, et al. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down’s syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15: 801-10.
Article Metrics
55
4